Anti-Obesity Prescription Drugs Market Size Was over USD 1095 Million in 2024 with 4.97% CAGR Estimation from 2018 to 2024
The report on Anti-Obesity Prescription Drugs Market by Drug Class (orlistat, phentermine and topiramate, bupropion and naltrexone, lorcaserin, liraglutide), by Distribution Channel (retail pharmacy, hospital pharmacy and online pharmacy), and by Age Group (pediatric and adult) trends analysis and forecasts up to 2024 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Anti-Obesity Prescription Drugs Market is projected to grow at...
View full press release